GlassScriptPhysician profile
John J Aschberger
NPI 1851327381
$275.99
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2022: $12.51.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $85.95 | 2019 | |
| Scilex Pharmaceuticals INC. | $66.40 | 2019 | |
| Pfizer INC. | $32.78 | 2019 | |
| Shionogi INC | $19.58 | 2019 | |
| Mdd US Operations, LLC | $17.45 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.51 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.17 | 2019 | |
| Biodelivery Sciences International, INC. | $12.13 | 2019 | |
| Collegium Pharmaceutical, INC. | $11.46 | 2019 | |
| Electronic Waveform Lab, INC. | $5.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Aschberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.